Skip to main content
Clinical Trials/NCT02149316
NCT02149316CompletedNot Applicable

Cardioprotective Effects of Remote Ischemic Preconditioning With Postconditioning of the Recipient on Donor Heart in Heart Transplantation Surgery

Chinese Academy of Medical Sciences, Fuwai Hospital2 sites in 1 country60 target enrollmentStarted: February 1, 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
60
Locations
2
Primary Endpoint
serum cardiac troponin I (cTnI)

Study Overview

Brief Summary

The purpose of this study is to determine whether remote ischemic preconditioning with postconditioning (RIPC+RIPostC) reduces myocardial injury and improves clinical outcomes in heart transplantation surgery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Double (Participant, Care Provider)

Eligibility Criteria

Ages
14 Years to 70 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • scheduled for elective orthotopic heart transplantation surgery

Exclusion Criteria

  • peripheral vascular disease affecting the upper arms
  • mechanical circulatory support before surgery
  • taking the antidiabetic sulphonylurea, glibenclamide
  • cold ischemic time of donor heart > 12 hours
  • repeated heart surgery

Outcomes

Primary Outcomes

serum cardiac troponin I (cTnI)

Time Frame: within 72 hours after aortic declamping

Secondary Outcomes

  • plasma microRNA-133b (miR-133b)(within 72 hours after aortic declamping)
  • plasma microRNA-208a (miR-208a)(within 72 hours after aortic declamping)

Investigators

Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Guyan Wang

The Chief of Infection-Control Department

Chinese Academy of Medical Sciences, Fuwai Hospital

Study Sites (2)

Loading locations...

Similar Trials